tirzepatide new england journal of medicine In the two SURMOUNT-OSA trials, researchers assessed the efficacy and safety for the treatment of adults with obstructive sleep apnea and obesity. Full results of both trials and Plain Language In the SUMMIT trial, researchers

Results and conclusions The researchers screened 709 participants between September 13 and November 22, 2021, of which the researchers randomly assigned 334 and 333 participants to oral semaglutide 50 mg and placebo groups, respectively, comprising the cumulative intention-to-treat analysis group

Kermanc P, Poganik T, mitek J, Hristov H, Tokova O, mitek K

We compare Semaglutide (Wegovy) vs

Either lower sermorelin dose or increase tirzepatide dose, never both simultaneously

Initial findings are promising, indicating semaglutide might offer a new management avenue, especially for those unrelieved by existing treatments

se recomienda usar mtodos anticonceptivos no orales o de respaldo durante 4 semanas despus del inicio y cada aumento de dosis [1] Puede aumentar el riesgo de hipoglucemia cuando se usa con insulina o secretagogos de insulina (sulfonilureas) Dolor muscular como efecto secundario de la tirzepatida El dolor muscular (mialgia) no figura entre los efectos secundarios ms comunes reportados en los ensayos clnicos pivotales de tirzepatida, como los estudios SURPASS para diabetes tipo 2 y SURMOUNT para prdida de peso